Tissue Diagnostics Market Size, Share, Analysis, Trends, Growth Report, 2030

Tissue Diagnostics Market

Tissue Diagnostics Market by Product (Consumables and Instruments); by Technology (Special Staining, Digital Pathology and Workflow Management, In situ Hybridization, and Immunohistochemistry); by Disease (Non-small Cell Lung Cancer, Prostate Cancer, Lymphoma, Gastric Cancer, Breast Cancer and Other Diseases); by End User (Contract Research Organizations, Research Laboratories, Pharmaceutical Companies, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-5022 Published Date: Nov-2019 Status : Published
Market Size in 2018 Market Forecast in 2025 CAGR (in %) Base Year
USD 3.86 Billion USD 6.30 Billion 7.3% 2018

Tissue Diagnostics Industry Perspective:

The Global Tissue Diagnostics Market Size was worth around USD 3.86 Billion in 2018 and is predicted to grow to around USD 6.30 Billion by 2025 with a compound annual growth rate (CAGR) of roughly 7.3% between 2019 and 2025.

The report covers forecast and analysis for the tissue diagnostics market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the tissue diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the tissue diagnostics market on a global as well as regional level.

Global Tissue Diagnostics Market Request Free Sample

In order to give the users of this report a comprehensive view on the tissue diagnostics market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the tissue diagnostics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the tissue diagnostics market on global and regional basis.

Tissue Diagnostics Market: Growth Factors

Tissue diagnostics is an important diagnostic tool for detection of various pathological conditions and is considered gold standard for cancer diagnosis. Tissue is removed from patient by medical procedure and is sent to pathology laboratory for evaluation by molecular, histologic and ultrastructural examination.

The demand for tissue diagnostics market is driven by increasing incidences of cancer all over the world, increasing healthcare expenditure, favorable reimbursement policies, technological advancements, and improvement in the infrastructure for diagnosis of cancer. Also increasing aging population, growing health awareness and increasing government initiatives to create awareness are factors that boost the market growth. However, high degree of consolidation, high initial capital investment, and R&D expenses may act as restraining factors for the market growth. Growing demand for personalized medicine and

Tissue Diagnostics Market: Segmentation

The study provides a crucial view on the tissue diagnostics by segmenting the market based on product, technology, disease, end user and region. All the segments of tissue diagnostics market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

Based on product, the global tissue diagnostics market is bifurcated into consumables and instruments. The instruments segment is sub-segmented into tissue-processing systems, scanners, slide-staining systems and other instruments. The consumables segment is sub segmented into probes, reagents, kits, and antibodies. The consumables segment accounted for the largest market share in 2018 whereas the instruments segment is expected to grow at a highest CAGR over the forecast period. Technological advancements and consistent use of consumables attribute to the large share of the consumables product segment.

Based on technology market is segmented into special staining, digital pathology and workflow management, in situ hybridization and immunohistochemistry.

The immunohistochemistry technology segment held largest market share in 2018. Increasing demand for in vitro diagnostics and availability of large number of products based on immunohistochemistry are factors that attribute to the largest market share in 2018.

The disease segment is divided into non-small cell lung cancer, prostate cancer, lymphoma, gastric cancer, breast cancer and other diseases. Breast cancer is the second leading type of cancer across the globe and increasing prevalence and awareness thus attribute to the largest market share of the breast cancer disease segment.

Contract research organizations, research laboratories, pharmaceutical companies, hospitals and others are end users of the tissue diagnostics market. Hospitals dominated the tissue diagnostics market in 2018 owing to large patient pool, availability of developed infrastructure and better accessibility. The research laboratory's end-user segment is expected to register rapid growth over the forecast period.

Tissue Diagnostics Market: Report Scope

Report Attributes Report Details
Report Name Tissue Diagnostics Market Research Report
Market Size in 2018 USD 3.86 Billion
Market Forecast in 2025 USD 6.30 Billion
Growth Rate CAGR of 7.3%
Number of Pages 255
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Abbott, Roche, Merck, Danaher, Sakura Finetek Japan, Thermo Fisher Scientific, Abcam, Agilent Technologies, QIAGEN, BD, Sienna Cancer Diagnostics, A. Menarini Diagnostics, Royal Philips, and Cell Signaling Technology among others.
Segments Covered By Product, By Technology, By Disease, By End User, By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Base Year 2018
Historical Year 2016 to 2018
Forecast Year 2019 - 2025
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Tissue Diagnostics Market: Regional Landscape

North America dominated the global tissue diagnostics market in 2018. Increasing cancer prevalence, the presence of developed R&D infrastructure, favorable reimbursement policies, and technological advancements are factors driving the market in this region. Europe was the second largest regional market. Growing research on tissue diagnosis, rise in R&D spending, presence of developed infrastructure, and increasing burden of cancer and other diseases are some of the factors that boost market growth in this region.

Latin America is expected to witness moderate growth over the forecast period. Asia Pacific region will exhibit the highest growth for the tissue diagnostics market in the coming years. Increasing geriatric population base, increasing healthcare spending and disposable income, health awareness, and infrastructure improvement are factors promoting tissue diagnostics market growth in Asia Pacific. Lack of awareness, funds, and infrastructure may attribute to slower growth in the Middle East and Africa.

Tissue Diagnostics Market: Competitive Space

Major players included in the report are

  • Abbott
  • Roche
  • Merck
  • Danaher
  • Sakura Finetek Japan
  • Thermo Fisher Scientific
  • Abcam
  • Agilent Technologies
  • QIAGEN
  • BD
  • Sienna Cancer Diagnostics
  • A. Menarini Diagnostics
  • Royal Philips
  • Cell Signaling Technology
  • among others.

The report segment of global tissue diagnostics market as follows:

Global Tissue Diagnostics Market: By Product

  • Instruments
    • Slide-staining systems
    • Scanners
    • Tissue-processing systems
    • Other instruments
  • Consumables
    • Antibodies
    • Kits
    • Reagents
    • Probes

Global Tissue Diagnostics Market: By Technology

  • Immunohistochemistry
  • In situ hybridization
  • Digital pathology
  • workflow management
  • Special staining

Global Tissue Diagnostics Market: By Disease

  • Breast cancer
  • Gastric cancer
  • Lymphoma
  • Prostate cancer
  • Non-small cell lung cancer
  • Other diseases

Global Tissue Diagnostics Market: By End User

  • Hospitals
  • Pharmaceutical companies
  • Research laboratories
  • Contract research organizations
  • Other end users

Global Tissue Diagnostics Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Tissue diagnostics examines and analyzes human tissue samples to diagnose diseases, disorders, and situations. This discipline studies tissue shape, composition, and behavior at the cellular and molecular level using histology, immunohistochemistry, molecular diagnostics, and microscopy. Medical diagnosis, therapy, and disease progression depend on tissue diagnostics. Pathologists, oncologists, and other medical experts utilize them to diagnose cancer, infections, inflammatory diseases, and more, improving patient care.

The demand for tissue diagnostics market is driven by increasing incidences of cancer all over the world, increasing healthcare expenditure, favorable reimbursement policies, technological advancements, and improvement in the infrastructure for diagnosis of cancer. 

According to the report, global demand for tissue diagnostics market was valued at approximately USD 3.86 billion in 2018, and is expected to generate revenue of around USD 6.30 billion by end of 2025, growing at a CAGR of around 7.3% between 2019 and 2025.

North America dominated the global tissue diagnostics market in 2018. Increasing cancer prevalence, presence of developed R&D infrastructure, favourable reimbursement policies, technological advancements are factors driving the market in this region. 

Major players included in the report are Abbott, Roche, Merck, Danaher, Sakura Finetek Japan, Thermo Fisher Scientific, Abcam, Agilent Technologies, QIAGEN, BD, Sienna Cancer Diagnostics, A. Menarini Diagnostics, Royal Philips, and Cell Signaling Technology among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed